607 related articles for article (PubMed ID: 27532478)
1. Former Abusers of Anabolic Androgenic Steroids Exhibit Decreased Testosterone Levels and Hypogonadal Symptoms Years after Cessation: A Case-Control Study.
Rasmussen JJ; Selmer C; Østergren PB; Pedersen KB; Schou M; Gustafsson F; Faber J; Juul A; Kistorp C
PLoS One; 2016; 11(8):e0161208. PubMed ID: 27532478
[TBL] [Abstract][Full Text] [Related]
2. Effects of Anabolic Androgenic Steroids on the Reproductive System of Athletes and Recreational Users: A Systematic Review and Meta-Analysis.
Christou MA; Christou PA; Markozannes G; Tsatsoulis A; Mastorakos G; Tigas S
Sports Med; 2017 Sep; 47(9):1869-1883. PubMed ID: 28258581
[TBL] [Abstract][Full Text] [Related]
3. Prolonged hypogonadism in males following withdrawal from anabolic-androgenic steroids: an under-recognized problem.
Kanayama G; Hudson JI; DeLuca J; Isaacs S; Baggish A; Weiner R; Bhasin S; Pope HG
Addiction; 2015 May; 110(5):823-31. PubMed ID: 25598171
[TBL] [Abstract][Full Text] [Related]
4. Increased blood pressure and aortic stiffness among abusers of anabolic androgenic steroids: potential effect of suppressed natriuretic peptides in plasma?
Rasmussen JJ; Schou M; Madsen PL; Selmer C; Johansen ML; Hovind P; Ulriksen PS; Faber J; Gustafsson F; Kistorp C
J Hypertens; 2018 Feb; 36(2):277-285. PubMed ID: 28863033
[TBL] [Abstract][Full Text] [Related]
5. Serum Insulin-like Factor 3 Levels Are Reduced in Former Androgen Users, Suggesting Impaired Leydig Cell Capacity.
Rasmussen JJ; Albrethsen J; Frandsen MN; Jørgensen N; Juul A; Kistorp C
J Clin Endocrinol Metab; 2021 Jun; 106(7):e2664-e2672. PubMed ID: 33693710
[TBL] [Abstract][Full Text] [Related]
6. Insulin sensitivity in relation to fat distribution and plasma adipocytokines among abusers of anabolic androgenic steroids.
Rasmussen JJ; Schou M; Selmer C; Johansen ML; Gustafsson F; Frystyk J; Dela F; Faber J; Kistorp C
Clin Endocrinol (Oxf); 2017 Sep; 87(3):249-256. PubMed ID: 28500659
[TBL] [Abstract][Full Text] [Related]
7. Factors predicting normalization of reproductive hormones after cessation of anabolic-androgenic steroids in men: a single center retrospective study.
Grant B; Campbell J; Pradeep A; Burns AD; Bassett P; Abbara A; Saket P; Minhas S; Dhillo WS; McVeigh J; Bhasin S; Jayasena CN
Eur J Endocrinol; 2023 Dec; 189(6):601-610. PubMed ID: 38102386
[TBL] [Abstract][Full Text] [Related]
8. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. I: Plasma luteinizing hormone, follicle stimulating hormone, testosterone, estradiol, and inhibin concentrations.
Wallace EM; Gow SM; Wu FC
J Clin Endocrinol Metab; 1993 Jul; 77(1):290-3. PubMed ID: 8325955
[TBL] [Abstract][Full Text] [Related]
9. [Case of androgenic anabolic steroid abuse caused hypogonadotropic hypogonadism].
Takayanagi A; Kobayashi K; Hashimoto K; Kato R; Masumori N; Itoh N; Tsukamoto T
Nihon Hinyokika Gakkai Zasshi; 2008 Nov; 99(7):729-32. PubMed ID: 19068689
[TBL] [Abstract][Full Text] [Related]
10. The use of post-cycle therapy is associated with reduced withdrawal symptoms from anabolic-androgenic steroid use: a survey of 470 men.
Grant B; Kean J; Vali N; Campbell J; Maden L; Bijral P; Dhillo WS; McVeigh J; Quinton R; Jayasena CN
Subst Abuse Treat Prev Policy; 2023 Nov; 18(1):66. PubMed ID: 37951896
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of undiagnosed testosterone deficiency in aging athletes: does exercise training influence the symptoms of male hypogonadism?
Di Luigi L; Sgrò P; Fierro V; Bianchini S; Battistini G; Magini V; Jannini EA; Lenzi A
J Sex Med; 2010 Jul; 7(7):2591-601. PubMed ID: 20141589
[TBL] [Abstract][Full Text] [Related]
12. Cardiac systolic dysfunction in past illicit users of anabolic androgenic steroids.
Rasmussen JJ; Schou M; Madsen PL; Selmer C; Johansen ML; Ulriksen PS; Dreyer T; Kümler T; Plesner LL; Faber J; Gustafsson F; Kistorp C
Am Heart J; 2018 Sep; 203():49-56. PubMed ID: 30015068
[TBL] [Abstract][Full Text] [Related]
13. Multiple forms of hypogonadism of central, peripheral or combined origin in males with Prader-Willi syndrome.
Radicioni AF; Di Giorgio G; Grugni G; Cuttini M; Losacco V; Anzuini A; Spera S; Marzano C; Lenzi A; Cappa M; Crinò A
Clin Endocrinol (Oxf); 2012 Jan; 76(1):72-7. PubMed ID: 21718342
[TBL] [Abstract][Full Text] [Related]
14. Somatic effects of AAS abuse: A 30-years follow-up study of male former power sports athletes.
Lindqvist Bagge AS; Rosén T; Fahlke C; Ehrnborg C; Eriksson BO; Moberg T; Thiblin I
J Sci Med Sport; 2017 Sep; 20(9):814-818. PubMed ID: 28389219
[TBL] [Abstract][Full Text] [Related]
15. Time course of the serum gonadotropin surge, inhibins, and anti-Müllerian hormone in normal newborn males during the first month of life.
Bergadá I; Milani C; Bedecarrás P; Andreone L; Ropelato MG; Gottlieb S; Bergadá C; Campo S; Rey RA
J Clin Endocrinol Metab; 2006 Oct; 91(10):4092-8. PubMed ID: 16849404
[TBL] [Abstract][Full Text] [Related]
16. Testicular anti-mullerian hormone secretion is stimulated by recombinant human FSH in patients with congenital hypogonadotropic hypogonadism.
Young J; Chanson P; Salenave S; Noël M; Brailly S; O'Flaherty M; Schaison G; Rey R
J Clin Endocrinol Metab; 2005 Feb; 90(2):724-8. PubMed ID: 15536161
[TBL] [Abstract][Full Text] [Related]
17. Anabolic androgenic steroid use is associated with ventricular dysfunction on cardiac MRI in strength trained athletes.
Luijkx T; Velthuis BK; Backx FJ; Buckens CF; Prakken NH; Rienks R; Mali WP; Cramer MJ
Int J Cardiol; 2013 Aug; 167(3):664-8. PubMed ID: 22459398
[TBL] [Abstract][Full Text] [Related]
18. [Peculiarity of recovery of the hypothalamic-pituitary-gonadal (hpg) axis, in men after using androgenic anabolic steroids].
Lykhonosov MP; Babenko AY; Makarin VA; Fedotov YN
Probl Endokrinol (Mosk); 2020 Aug; 66(1):104-112. PubMed ID: 33351319
[TBL] [Abstract][Full Text] [Related]
19. Relationships between FSH, inhibin B, anti-Mullerian hormone, and testosterone during long-term treatment with the GnRH-agonist histrelin in patients with prostate cancer.
Eldar-Geva T; Liberty G; Chertin B; Fridmans A; Farkas A; Margalioth EJ; Spitz IM
Eur J Endocrinol; 2010 Jan; 162(1):177-81. PubMed ID: 19820037
[TBL] [Abstract][Full Text] [Related]
20. [The frequency of formation of a motivated refusal to take androgenic anabolic steroids by men with recreational activity].
Lykhonosov MP; Babenko AY; Makarin VA; Fedotov YN
Probl Endokrinol (Mosk); 2019 Nov; 65(5):341-350. PubMed ID: 32202738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
